Survival in polymyositis: corticosteroids and risk factors.

J. R. Carpenter; T. W. Bunch; A. G. Engel; P. C. O'Brien

Survival in polymyositis: corticosteroids and risk factors.

J. R. Carpenter, T. W. Bunch, A. G. Engel, P. C. O'Brien

Neurology

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Abstract

Thirty-one polymyositis patients treated with low-dose corticosteroid were age and sex matched with 31 polymyositis patients treated with high-dose corticosteroid. Although disease severity at onset of the study was similar in the groups, no statistically significant difference in survival was found. The death rate in each group was greater than normal. The presence of dysphagia or severe muscle weakness lessened the chances of survival. Controlled trials with other drugs should be carried out.

Original language	English (US)
Pages (from-to)	207-214
Number of pages	8
Journal	Journal of Rheumatology
Volume	4
Issue number	2
State	Published - Jun 1977

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology

Cite this

@article{9decd47b6d6f4cfda7e5d17f0ea09d98,

title = "Survival in polymyositis: corticosteroids and risk factors.",

abstract = "Thirty-one polymyositis patients treated with low-dose corticosteroid were age and sex matched with 31 polymyositis patients treated with high-dose corticosteroid. Although disease severity at onset of the study was similar in the groups, no statistically significant difference in survival was found. The death rate in each group was greater than normal. The presence of dysphagia or severe muscle weakness lessened the chances of survival. Controlled trials with other drugs should be carried out.",

author = "Carpenter, {J. R.} and Bunch, {T. W.} and Engel, {A. G.} and O'Brien, {P. C.}",

year = "1977",

month = jun,

language = "English (US)",

volume = "4",

pages = "207--214",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "2",

}

TY - JOUR

T1 - Survival in polymyositis

T2 - corticosteroids and risk factors.

AU - Carpenter, J. R.

AU - Bunch, T. W.

AU - Engel, A. G.

AU - O'Brien, P. C.

PY - 1977/6

Y1 - 1977/6

N2 - Thirty-one polymyositis patients treated with low-dose corticosteroid were age and sex matched with 31 polymyositis patients treated with high-dose corticosteroid. Although disease severity at onset of the study was similar in the groups, no statistically significant difference in survival was found. The death rate in each group was greater than normal. The presence of dysphagia or severe muscle weakness lessened the chances of survival. Controlled trials with other drugs should be carried out.

AB - Thirty-one polymyositis patients treated with low-dose corticosteroid were age and sex matched with 31 polymyositis patients treated with high-dose corticosteroid. Although disease severity at onset of the study was similar in the groups, no statistically significant difference in survival was found. The death rate in each group was greater than normal. The presence of dysphagia or severe muscle weakness lessened the chances of survival. Controlled trials with other drugs should be carried out.

UR - http://www.scopus.com/inward/record.url?scp=0017499877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017499877&partnerID=8YFLogxK

M3 - Article

C2 - 881699

AN - SCOPUS:0017499877

SN - 0315-162X

VL - 4

SP - 207

EP - 214

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 2

ER -

Survival in polymyositis: corticosteroids and risk factors.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this